Journal of Addiction Medicine

Papers
(The H4-Index of Journal of Addiction Medicine is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.82
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions53
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine44
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease41
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation40
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails39
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes39
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–201933
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study28
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial27
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review27
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era26
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations25
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language25
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder25
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder24
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals24
Letter to the Editor (RE: Polles et al)23
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations22
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report21
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder20
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study20
0.15200400352478